These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26553116)

  • 1. Association of homocysteine level and vascular burden and cognitive function in middle-aged and older adults with chronic kidney disease.
    Yeh YC; Huang MF; Hwang SJ; Tsai JC; Liu TL; Hsiao SM; Yang YH; Kuo MC; Chen CS
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):723-30. PubMed ID: 26553116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
    Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
    Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Kidney Disease and Subclinical Brain Infarction Increase the Risk of Vascular Cognitive Impairment: The Sefuri Study.
    Yao H; Araki Y; Takashima Y; Uchino A; Yuzuriha T; Hashimoto M
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):420-424. PubMed ID: 28341210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease.
    Yeh YC; Kuo YT; Huang MF; Hwang SJ; Tsai JC; Kuo MC; Chen CS
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1826-1832. PubMed ID: 31418471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine, rather than age of onset, is a better predictor for cognitive function in older adults with bipolar disorder.
    Chen PH; Liu HC; Lu ML; Chen CH; Chang CJ; Chiu WC; Sun IW; Liu SI; Tsai SY; Chiu CC; Stewart R
    Int J Geriatr Psychiatry; 2019 Oct; 34(10):1473-1480. PubMed ID: 31111977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Impairment and Progression of CKD.
    Kurella Tamura M; Yaffe K; Hsu CY; Yang J; Sozio S; Fischer M; Chen J; Ojo A; DeLuca J; Xie D; Vittinghoff E; Go AS;
    Am J Kidney Dis; 2016 Jul; 68(1):77-83. PubMed ID: 26972681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration.
    Lai MMY; Sharman MJ; Ames DJ; Ellis KA; Cox KL; Hepworth G; Desmond P; Cyarto EV; Martins RN; Masters CL; Lautenschlager NT
    J Alzheimers Dis; 2020; 74(1):163-171. PubMed ID: 32007955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis.
    Paraizo Mde A; Almeida AL; Pires LA; Abrita RS; Crivellari MH; Pereira Bdos S; Fernandes NM; Bastos MG
    J Bras Nefrol; 2016 Mar; 38(1):31-41. PubMed ID: 27049362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial.
    Foster R; Walker S; Brar R; Hiebert B; Komenda P; Rigatto C; Storsley L; Prasad B; Bohm C; Tangri N
    Am J Nephrol; 2016; 44(6):473-480. PubMed ID: 27798938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
    Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
    Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical Environment.
    Gronewold J; Todica O; Seidel UK; Volsek M; Kribben A; Bruck H; Hermann DM
    PLoS One; 2016; 11(11):e0166530. PubMed ID: 27835681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Tian S; Han J; Huang R; Sun J; Cai R; Shen Y; Wang S
    J Alzheimers Dis; 2017; 58(4):1163-1173. PubMed ID: 28550262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine and cognitive decline in older hypertensive subjects.
    Narayan SK; Saxby BK; Firbank MJ; O'Brien JT; Harrington F; McKeith IG; Hansrani M; Stansby G; Ford GA
    Int Psychogeriatr; 2011 Dec; 23(10):1607-15. PubMed ID: 21554791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review.
    Zammit AR; Katz MJ; Bitzer M; Lipton RB
    Alzheimer Dis Assoc Disord; 2016; 30(4):357-366. PubMed ID: 27861179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of executive function after dialysis initiation in adults with chronic kidney disease.
    Kurella Tamura M; Vittinghoff E; Hsu CY; Tam K; Seliger SL; Sozio S; Fischer M; Chen J; Lustigova E; Strauss L; Deo R; Go AS; Yaffe K;
    Kidney Int; 2017 Apr; 91(4):948-953. PubMed ID: 28139292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and vascular function in older adults with and without CKD.
    Hannan M; Collins EG; Phillips SA; Quinn L; Steffen A; Bronas UG
    Aging Clin Exp Res; 2021 Jul; 33(7):1885-1894. PubMed ID: 32902822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine level and cognitive function in patients with arterial disease: the second manifestations of ARTerial Disease Study.
    van Raamt AF; Kalmijn S; Mali WP; van Zandvoort MJ; van der Graaf Y;
    J Am Geriatr Soc; 2006 Apr; 54(4):575-9. PubMed ID: 16686865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of vascular risk factors on cognitive function in early Parkinson's disease.
    Doiron M; Langlois M; Dupré N; Simard M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):288-297. PubMed ID: 28509343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Function in Patients With Chronic Kidney Disease: Challenges in Neuropsychological Assessments.
    Schneider SM; Kielstein JT; Braverman J; Novak M
    Semin Nephrol; 2015 Jul; 35(4):304-10. PubMed ID: 26355249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.